<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      version="3.7"
      xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
   <titleInfo>
      <title>In silico, in vitro screening of plant extracts for anti-SARS-CoV-2 activity and evaluation of their acute and sub-acute toxicity</title>
   </titleInfo>
   <name type="personal" usage="primary">
      <namePart type="given">Damle</namePart>
      <namePart type="family">Latha</namePart>
      <displayForm>Latha, Damle</displayForm>
      <affiliation>Computational Biology, Atrimed Biotech LLP, Banglore, 560100, India</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Damle</namePart>
      <namePart type="family">Hrishikesh</namePart>
      <displayForm>Hrishikesh, Damle</displayForm>
      <affiliation>Atrimed Pharmaceuticals Pvt. Ltd, Banglore, 560001, India</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Ganju</namePart>
      <namePart type="family">Shiban</namePart>
      <displayForm>Shiban, Ganju</displayForm>
      <affiliation>Atrimed Pharmaceuticals Pvt. Ltd, Banglore, 560001, India</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">C</namePart>
      <namePart type="family">Chandrashekar</namePart>
      <displayForm>Chandrashekar, C</displayForm>
      <affiliation>Computational Biology, Atrimed Biotech LLP, Banglore, 560100, India</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">BR</namePart>
      <namePart type="family">Bharath</namePart>
      <displayForm>Bharath, BR</displayForm>
      <affiliation>Computational Biology, Atrimed Biotech LLP, Banglore, 560100, India</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <typeOfResource>text</typeOfResource>
   <genre>article</genre>
   <originInfo>
      <dateIssued encoding="w3cdtf" keyDate="yes">2022-05</dateIssued>
   </originInfo>
   <language>
      <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
      <languageTerm type="text">English</languageTerm>
   </language>
   <abstract>In the absence of a specific drug for COVID 19, treatment with plant extracts could be an option worthy of further investigation and has motivated to evaluate the safety and anti-SARS-CoV-2 activity of plant extracts. To screen the phytochemicals for anti-SARS-CoV-2 in silico and evaluate their safety and efficacy in vitro and in vivo. The phytochemicals for anti-SARS-CoV-2 were screened in silico using molecular docking. The hits generated from in silico screening were subjected for extraction, isolation and purification. The anti-SARS-CoV-2 activity of Zanthoxylum piperitum (E1), Withania somnifera (E2), Calophyllum inophyllum (E3), Andrographis paniculata (E4), Centella asiatica (E5) ethanol extracts. The aerial parts were used for E1, E3, E4, E5 and root was used for E2. The in vitro safety and anti-SARS-CoV-2 activity of plant methanol extracts were performed in VeroE6 cells using Remdesivir as positive control. The acute and sub-acute toxicity study was performed in Wistar male and female rats. The percentage of cell viability for E4, E5 and E2 treated VeroE6 cells were remarkably good on the 24th and 48th hour of treatment. The in vitro anti-SARS-CoV-2 activity of E4, E5 and E2 were significant for both E gene and N gene. The percentage of SARS-CoV-2 inhibition for E4 was better than Remdesivir. For E gene and N gene, Remdesivir showed IC₅₀ of 0.15 µM and 0.11 µM respectively, For E gene and N gene, E4 showed IC₅₀ of 1.18 µg and 1.16 µg respectively. Taking the clue from in vitro findings, the E4, E5 and E2 were combined (E 4.5.2) and evaluated for acute and sub-acute toxicity in Wistar male and female rats. No statistically significant difference in haematological, biochemical and histopathological parameters were noticed. The study demonstrated the anti-SARS-CoV-2 activity in vitro and safety of plant extracts in both in vitro and in vivo experimental conditions. </abstract>
   <subject>
      <topic>Molecular docking</topic>
   </subject>
   <subject>
      <topic>Plant extracts</topic>
   </subject>
   <subject>
      <topic>Cytotoxicity</topic>
   </subject>
   <subject>
      <topic>Anti-SARS-CoV-2</topic>
   </subject>
   <subject>
      <topic>In vivo toxicity</topic>
   </subject>
   <relatedItem type="host">
      <titleInfo>
         <title>Phytomedicine Plus</title>
      </titleInfo>
      <originInfo>
         <publisher>Elsevier B.V.</publisher>
      </originInfo>
      <identifier type="issn">2667-0313</identifier>
      <part>
         <detail type="volume">
            <number>2</number>
            <caption>v.</caption>
         </detail>
         <detail type="issue">
            <number>2</number>
            <caption>no.</caption>
         </detail>
         <text type="display-date">May 2022</text>
         <text type="year">2022</text>
         <text type="month">May</text>
         <extent unit="pages">
            <start>100233</start>
         </extent>
      </part>
   </relatedItem>
   <identifier type="doi">10.1016/j.phyplu.2022.100233</identifier>
   <location>
      <url>http://dx.doi.org/10.1016/j.phyplu.2022.100233</url>
   </location>
   <identifier type="pii">S2667-0313(22)00019-7</identifier>
   <accessCondition type="use and reproduction"
                    displayLabel="Creative Commons Attribution 4.0 Generic (CC BY-NC-ND 4.0)">
      <program xmlns="https://data.crossref.org/schemas/AccessIndicators.xsd">
         <licence_ref applies_to="reuse" start_date="2022-01-29"/>
         <licence_ref>http://creativecommons.org/licenses/by-nc-nd/4.0/</licence_ref>
      </program>
   </accessCondition>
   <extension>
      <vendorName/>
      <archiveFile/>
      <originalFile>file:/C:/Users/Carlos.Martinez/OneDrive%20-%20USDA/XML_projects/OpenAccess/OpenAccess/transform/source/sourcefiles/576450669703096969-00001/2667-0313/S2667031322X0002X/S2667031322000197/S2667031322000197.xml</originalFile>
      <workingDirectory>C:\Users\Carlos.Martinez\OneDrive - USDA\XML_projects\OpenAccess\OpenAccess\transform\result\</workingDirectory>
   </extension>
</mods>
